| 000 | 01513 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512055517.0 | ||
| 264 | 0 | _c19860619 | |
| 008 | 198606s 0 0 eng d | ||
| 022 | _a0361-5960 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVogler, W R | |
| 245 | 0 | 0 |
_aRandomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study. _h[electronic resource] |
| 260 |
_bCancer treatment reports _cApr 1986 |
||
| 300 |
_a455-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAminoacridines _xadverse effects |
| 650 | 0 | 4 | _aAmsacrine |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNaphthacenes _xtherapeutic use |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aPreisler, H D | |
| 700 | 1 | _aWinton, E F | |
| 700 | 1 | _aGottlieb, A J | |
| 700 | 1 | _aGoldberg, J | |
| 700 | 1 | _aBrennan, J | |
| 700 | 1 | _aGrunwald, H | |
| 700 | 1 | _aRai, K | |
| 700 | 1 | _aBrowman, G | |
| 700 | 1 | _aMiller, K B | |
| 773 | 0 |
_tCancer treatment reports _gvol. 70 _gno. 4 _gp. 455-9 |
|
| 999 |
_c3522120 _d3522120 |
||